On the other hand, most of the malignant thyroid tumors (59/95) demonstrated moderate (2+) to strong (3+) cell membrane immunoreactivity for dysadherin (62% vs. 2% in benign group, p<0.001) with diffused pattern localized predominantly to the cell membrane. This evidence concerns the gene FXYD5 and thyroid tumor.